🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out our editorial on the analysis of recurrent and total events from the #ISCHEMIA trial. Still many unanswered questions for future trials to address! Dr Roxana Mehran European Society of Cardiology Journals EHJ Editor-in-Chief academic.oup.com/eurheartj/adva…

During #TCT2021, Cardiology Fellow, Dr. Carlo Andrea Pivato, presented his research which found that among high-risk #patients undergoing #PCI, the effects of ticagrelor #monotherapy were consistent across different #BMI categories.

🌟New data from #XIENCE 28/90 published in JACC Journals today! Among #HBR pts undergoing noncomplex #PCI, 1- vs 3-month DAPT: ↔️Ischemic events (death or MI) ⬇️Bleeding (esp between 31-90 days) Should 1-month DAPT be the new standard? Marco Valgimigli Dr Roxana Mehran jacc.org/doi/10.1016/j.…

It's academics, baby.

POEM findings are out 💥 In a 🌰: a 1-month DAPT regimen is safe and effective in high #bleeding risk patients undergoing #PCI with the Synergy bioresorbable-polymer EES! 👉doi.org/10.1161/JAHA.1… JAHA Giulio Stefanini @gcondorelli Luca Testa Raffaele Piccolo Valeria Paradies

Ecco i consigli della Società Italiana di Medicina Interna su come difendersi dal caldo. Alma Grandin

Finally out State-of-the-Art Review on antithrombotic drug 💊 #reversal and #removal in patients in active or imminent threat of major bleeding🩸 Read more in the #EHJ 📰 Dr Roxana Mehran Nicolas Amabile Mauro Chiarito

Waiting for new updates about ADCs at ESMO - Eur. Oncology Breast 2023, here we discuss the role of Sacituzumab Govitecan in HR+ HER2- ABC patients under the mentorship Prof Lucia Del Mastro atm.amegroups.com/article/view/1…

Another big hit 🎯 for #P2Y12-inhibitor monotherapy for secondary prevention in CAD patients🫀 Time for routine implementation into clinical practice? #PANTHER JACC Journals

#TCT2023 - Superb presentation by Dr Roxana Mehran on our work with the xDAPT model 🤖💡Machine learning showed excellent performance in predicting ischemic and bleeding risk post-PCI. Risk scores just got a game-changer! #MachineLearning #PCI TCT Conference

Check out our last review of “Impact of Immunity on Coronary Artery Disease”: nice bridge between Cardiology and Oncology, a mandatory interplay for best clinical practice mdpi.com/2537532 #mdpilife via Life MDPI MDPI Matteo Nardin

La Società Italiana di Medicina Interna chiede che vengano affrontate le criticità del  settore a partire dalla #carenza di #medici #MedicinaInterna #SIMI quotidianosanita.it/m/lavoro-e-pro…

This is still one of my favorites.

Honored to present our data about premenopausal women treated with LHRHa and AI, who do not achieve adeguate ovarian suppressions. Many thanks to Matteo Lambertini, MD PhD for support and mentorship, and to Francesca Poggio and Lucia Del Mastro for idea and suggestions Università di Genova Ospedale San Martino Genova

#notobaccoday #noalfumo #MedicinaInterna #SIMI

📢 Primo Annuncio - 125° Congresso Nazionale SIMI 🗓️11 al 13 ottobre 🗺️ Palacongressi, Rimini simi2024.it

Scientists need more time to think 🧠 nature

Randomized trials are the gold standard in clinical research, providing the strongest evidence for treatment effectiveness. However, they come with their own challenges and limitations Join Emanuele Barbato & me on Sept 4th as we discuss pitfalls and biases of RCTs 👉Link below

125° CONGRESSO NAZIONALE SIMI Programma e iscrizioni: simi.it/events/125-con… #MedicinaInterna #Congresso #Formazione #Networking

Honored and proud to present our data on suboptimal ovarian suppression as adjuvant treatment for HR+ EBC, receiving #SABCS24 Clinical Scholar Award! A heartfelt thanks to my daily guide of the last 4 years, Francesca Poggio , and my mentors Matteo Lambertini, MD PhD Lucia Del Mastro 🙏🏼OncoAlert